Cubist Systematic Strategies’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $88.2M | Buy |
903,124
+451,164
| +100% | +$46.7M | 0.42% | 11 |
|
|
2025
Q2 | $48.5M | Sell |
451,960
-377,032
| -45% | -$38.1M | 0.22% | 75 |
|
|
2025
Q1 | $83.6M | Buy |
828,992
+731,023
| +746% | +$73.6M | 0.51% | 5 |
|
|
2024
Q4 | $8.75M | Buy |
97,969
+59,950
| +158% | +$5.28M | 0.05% | 529 |
|
|
2024
Q3 | $3.19M | Buy |
38,019
+7,788
| +26% | +$614K | 0.02% | 1127 |
|
|
2024
Q2 | $2.33M | Sell |
30,231
-130,644
| -81% | -$9.56M | 0.02% | 1231 |
|
|
2024
Q1 | $11M | Sell |
160,875
-21,983
| -12% | -$1.41M | 0.06% | 462 |
|
|
2023
Q4 | $10.6M | Buy |
+182,858
| New | +$9.76M | 0.07% | 425 |
|
|
2023
Q3 | – | Sell |
-664,234
| Closed | -$34.8M | – | 3370 |
|
|
2023
Q2 | $35.9M | Buy |
664,234
+584,518
| +733% | +$30.5M | 0.24% | 45 |
|
|
2023
Q1 | $3.99M | Buy |
79,716
+60,764
| +321% | +$2.86M | 0.02% | 1106 |
|
|
2022
Q4 | $877K | Sell |
18,952
-172
| -0.9% | -$7.45K | 0.01% | 2578 |
|
|
2022
Q3 | $741K | Sell |
19,124
-66,206
| -78% | -$2.66M | ﹤0.01% | 2872 |
|
|
2022
Q2 | $3.18M | Buy |
85,330
+27,442
| +47% | +$1.12M | 0.02% | 1402 |
|
|
2022
Q1 | $2.56M | Buy |
57,888
+22,609
| +64% | +$980K | 0.02% | 1274 |
|
|
2021
Q4 | $1.5M | Sell |
35,279
-18,546
| -34% | -$779K | 0.01% | 1616 |
|
|
2021
Q3 | $2.33M | Sell |
53,825
-304,177
| -85% | -$13.5M | 0.03% | 910 |
|
|
2021
Q2 | $15.3M | Buy |
358,002
+233,125
| +187% | +$9.81M | 0.17% | 105 |
|
|
2021
Q1 | $4.83M | Sell |
124,877
-558,131
| -82% | -$21.1M | 0.06% | 477 |
|
|
2020
Q4 | $24.6M | Buy |
683,008
+131,908
| +24% | +$4.75M | 0.34% | 16 |
|
|
2020
Q3 | $21.1M | Buy |
551,100
+488,728
| +784% | +$18.8M | 0.31% | 22 |
|
|
2020
Q2 | $2.19M | Sell |
62,372
-230,559
| -79% | -$8.3M | 0.04% | 728 |
|
|
2020
Q1 | $9.56M | Buy |
292,931
+161,062
| +122% | +$6.29M | 0.26% | 67 |
|
|
2019
Q4 | $5.96M | Sell |
131,869
-1,946
| -1% | -$81.4K | 0.11% | 234 |
|
|
2019
Q3 | $5.45M | Buy |
133,815
+105,351
| +370% | +$4.46M | 0.11% | 256 |
|
|
2019
Q2 | $1.22M | Sell |
28,464
-83,010
| -74% | -$3.19M | 0.02% | 921 |
|
|
2019
Q1 | $4.28M | Buy |
111,474
+108,912
| +4,251% | +$4.16M | 0.14% | 177 |
|
|
2018
Q4 | $91K | Sell |
2,562
-9,709
| -79% | -$352K | ﹤0.01% | 1770 |
|
|
2018
Q3 | $472K | Sell |
12,271
-38,834
| -76% | -$1.36M | 0.03% | 876 |
|
|
2018
Q2 | $1.67M | Buy |
51,105
+1,547
| +3% | +$46.7K | 0.08% | 298 |
|
|
2018
Q1 | $1.35M | Sell |
49,558
-457,218
| -90% | -$12.4M | 0.08% | 329 |
|
|
2017
Q4 | $12.6M | Buy |
506,776
+493,483
| +3,712% | +$13.6M | 0.67% | 3 |
|
|
2017
Q3 | $388K | Sell |
13,293
-35,045
| -72% | -$968K | 0.02% | 989 |
|
|
2017
Q2 | $1.34M | Buy |
48,338
+17,683
| +58% | +$469K | 0.09% | 310 |
|
|
2017
Q1 | $762K | Sell |
30,655
-50,721
| -62% | -$1.23M | 0.05% | 456 |
|
|
2016
Q4 | $1.76M | Buy |
81,376
+34,772
| +75% | +$759K | 0.14% | 180 |
|
|
2016
Q3 | $1.11M | Sell |
46,604
-161,788
| -78% | -$3.86M | 0.07% | 374 |
|
|
2016
Q2 | $4.87M | Buy |
208,392
+52,045
| +33% | +$1.13M | 0.28% | 40 |
|
|
2016
Q1 | $2.94M | Sell |
156,347
-11,950
| -7% | -$210K | 0.17% | 124 |
|
|
2015
Q4 | $3.1M | Buy |
168,297
+160,403
| +2,032% | +$2.87M | 0.18% | 116 |
|
|
2015
Q3 | $130K | Sell |
7,894
-241,303
| -97% | -$4.12M | 0.01% | 1584 |
|
|
2015
Q2 | $4.41M | Buy |
249,197
+106,426
| +75% | +$1.9M | 0.22% | 86 |
|
|
2015
Q1 | $2.53M | Buy |
142,771
+55,128
| +63% | +$871K | 0.12% | 199 |
|
|
2014
Q4 | $1.16M | Sell |
87,643
-335,926
| -79% | -$4.29M | 0.06% | 444 |
|
|
2014
Q3 | $5M | Buy |
423,569
+310,184
| +274% | +$3.91M | 0.31% | 40 |
|
|
2014
Q2 | $1.45M | Buy |
+113,385
| New | +$1.47M | 0.09% | 343 |
|
Other funds holding BSX
Cubist Systematic Strategies's BSX Position: Q3 2025 in Review
Cubist Systematic Strategies increased its Boston Scientific (BSX) stake by 100% in Q3 2025, buying an estimated $46.7M and bringing the position to 903,124 shares worth $88.2M. The position accounts for 0.42% of the portfolio, ranked #11.
Cubist Systematic Strategies first reported a position in BSX in Q2 2014 and has held it in 45 quarters since. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.
- Cubist Systematic Strategies held 903,124 shares of Boston Scientific worth $88.2M as of Q3 2025.
- Cubist Systematic Strategies bought 451,164 Boston Scientific shares in Q3 2025, an estimated $46.7M.
- Boston Scientific made up 0.42% of Cubist Systematic Strategies's portfolio in Q3 2025, its #11 holding.
- Cubist Systematic Strategies first reported a position in Boston Scientific in Q2 2014 and has held it in 45 quarters since.
- 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.